These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33342929)

  • 1. Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai, China.
    Su Y; Ling Y; Ma Y; Tao L; Miao Q; Shi Q; Pan J; Lu H; Hu B
    Biosci Trends; 2021 Jan; 14(6):408-414. PubMed ID: 33342929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].
    Chen J; Liu D; Liu L; Liu P; Xu Q; Xia L; Ling Y; Huang D; Song S; Zhang D; Qian Z; Li T; Shen Y; Lu H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(2):215-219. PubMed ID: 32391667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.
    Mikulska M; Nicolini LA; Signori A; Di Biagio A; Sepulcri C; Russo C; Dettori S; Berruti M; Sormani MP; Giacobbe DR; Vena A; De Maria A; Dentone C; Taramasso L; Mirabella M; Magnasco L; Mora S; Delfino E; Toscanini F; Balletto E; Alessandrini AI; Baldi F; Briano F; Camera M; Dodi F; Ferrazin A; Labate L; Mazzarello G; Pincino R; Portunato F; Tutino S; Barisione E; Bruzzone B; Orsi A; Schenone E; Rosseti N; Sasso E; Da Rin G; Pelosi P; Beltramini S; Giacomini M; Icardi G; Gratarola A; Bassetti M
    PLoS One; 2020; 15(8):e0237831. PubMed ID: 32817707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Göpel S; Bethge W; Martus P; Kreth F; Iftner T; Joos S; Döbele S; Mordmüller B; Kremsner P; Ettrich T; Seufferlein T; Bitzer M; Malek N
    Trials; 2020 Jul; 21(1):635. PubMed ID: 32650818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID-19.
    Lauriola M; Pani A; Ippoliti G; Mortara A; Milighetti S; Mazen M; Perseghin G; Pastori D; Grosso P; Scaglione F
    Clin Transl Sci; 2020 Nov; 13(6):1071-1076. PubMed ID: 32926573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
    Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
    Self WH; Semler MW; Leither LM; Casey JD; Angus DC; Brower RG; Chang SY; Collins SP; Eppensteiner JC; Filbin MR; Files DC; Gibbs KW; Ginde AA; Gong MN; Harrell FE; Hayden DL; Hough CL; Johnson NJ; Khan A; Lindsell CJ; Matthay MA; Moss M; Park PK; Rice TW; Robinson BRH; Schoenfeld DA; Shapiro NI; Steingrub JS; Ulysse CA; Weissman A; Yealy DM; Thompson BT; Brown SM; ; Steingrub J; Smithline H; Tiru B; Tidswell M; Kozikowski L; Thornton-Thompson S; De Souza L; Hou P; Baron R; Massaro A; Aisiku I; Fredenburgh L; Seethala R; Johnsky L; Riker R; Seder D; May T; Baumann M; Eldridge A; Lord C; Shapiro N; Talmor D; O’Mara T; Kirk C; Harrison K; Kurt L; Schermerhorn M; Banner-Goodspeed V; Boyle K; Dubosh N; Filbin M; Hibbert K; Parry B; Lavin-Parsons K; Pulido N; Lilley B; Lodenstein C; Margolin J; Brait K; Jones A; Galbraith J; Peacock R; Nandi U; Wachs T; Matthay M; Liu K; Kangelaris K; Wang R; Calfee C; Yee K; Hendey G; Chang S; Lim G; Qadir N; Tam A; Beutler R; Levitt J; Wilson J; Rogers A; Vojnik R; Roque J; Albertson T; Chenoweth J; Adams J; Pearson S; Juarez M; Almasri E; Fayed M; Hughes A; Hillard S; Huebinger R; Wang H; Vidales E; Patel B; Ginde A; Moss M; Baduashvili A; McKeehan J; Finck L; Higgins C; Howell M; Douglas I; Haukoos J; Hiller T; Lyle C; Cupelo A; Caruso E; Camacho C; Gravitz S; Finigan J; Griesmer C; Park P; Hyzy R; Nelson K; McDonough K; Olbrich N; Williams M; Kapoor R; Nash J; Willig M; Ford H; Gardner-Gray J; Ramesh M; Moses M; Ng Gong M; Aboodi M; Asghar A; Amosu O; Torres M; Kaur S; Chen JT; Hope A; Lopez B; Rosales K; Young You J; Mosier J; Hypes C; Natt B; Borg B; Salvagio Campbell E; Hite RD; Hudock K; Cresie A; Alhasan F; Gomez-Arroyo J; Duggal A; Mehkri O; Hastings A; Sahoo D; Abi Fadel F; Gole S; Shaner V; Wimer A; Meli Y; King A; Terndrup T; Exline M; Pannu S; Robart E; Karow S; Hough C; Robinson B; Johnson N; Henning D; Campo M; Gundel S; Seghal S; Katsandres S; Dean S; Khan A; Krol O; Jouzestani M; Huynh P; Weissman A; Yealy D; Scholl D; Adams P; McVerry B; Huang D; Angus D; Schooler J; Moore S; Files C; Miller C; Gibbs K; LaRose M; Flores L; Koehler L; Morse C; Sanders J; Langford C; Nanney K; MdalaGausi M; Yeboah P; Morris P; Sturgill J; Seif S; Cassity E; Dhar S; de Wit M; Mason J; Goodwin A; Hall G; Grady A; Chamberlain A; Brown S; Bledsoe J; Leither L; Peltan I; Starr N; Fergus M; Aston V; Montgomery Q; Smith R; Merrill M; Brown K; Armbruster B; Harris E; Middleton E; Paine R; Johnson S; Barrios M; Eppensteiner J; Limkakeng A; McGowan L; Porter T; Bouffler A; Leahy JC; deBoisblanc B; Lammi M; Happel K; Lauto P; Self W; Casey J; Semler M; Collins S; Harrell F; Lindsell C; Rice T; Stubblefield W; Gray C; Johnson J; Roth M; Hays M; Torr D; Zakaria A; Schoenfeld D; Thompson T; Hayden D; Ringwood N; Oldmixon C; Ulysse C; Morse R; Muzikansky A; Fitzgerald L; Whitaker S; Lagakos A; Brower R; Reineck L; Aggarwal N; Bienstock K; Freemer M; Maclawiw M; Weinmann G; Morrison L; Gillespie M; Kryscio R; Brodie D; Zareba W; Rompalo A; Boeckh M; Parsons P; Christie J; Hall J; Horton N; Zoloth L; Dickert N; Diercks D
    JAMA; 2020 Dec; 324(21):2165-2176. PubMed ID: 33165621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
    Ling Y; Xu SB; Lin YX; Tian D; Zhu ZQ; Dai FH; Wu F; Song ZG; Huang W; Chen J; Hu BJ; Wang S; Mao EQ; Zhu L; Zhang WH; Lu HZ
    Chin Med J (Engl); 2020 May; 133(9):1039-1043. PubMed ID: 32118639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019.
    Kim JW; Kim EJ; Kwon HH; Jung CY; Kim KC; Choe JY; Hong HL
    Korean J Intern Med; 2021 Mar; 36(Suppl 1):S253-S263. PubMed ID: 32536150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: Results of a retrospective observational study in the French overseas department of Réunion Island.
    Dubernet A; Larsen K; Masse L; Allyn J; Foch E; Bruneau L; Maillot A; Lagrange-Xelot M; Thomas V; Jaffar-Bandjee MC; Gauzere L; Raffray L; Borsu K; Dibernardo S; Renaud S; André M; Moreau D; Jabot J; Coolen-Allou N; Allou N
    J Glob Antimicrob Resist; 2020 Dec; 23():1-3. PubMed ID: 32828896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.
    Abella BS; Jolkovsky EL; Biney BT; Uspal JE; Hyman MC; Frank I; Hensley SE; Gill S; Vogl DT; Maillard I; Babushok DV; Huang AC; Nasta SD; Walsh JC; Wiletyo EP; Gimotty PA; Milone MC; Amaravadi RK;
    JAMA Intern Med; 2021 Feb; 181(2):195-202. PubMed ID: 33001138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial.
    Barnabas RV; Brown ER; Bershteyn A; Stankiewicz Karita HC; Johnston C; Thorpe LE; Kottkamp A; Neuzil KM; Laufer MK; Deming M; Paasche-Orlow MK; Kissinger PJ; Luk A; Paolino K; Landovitz RJ; Hoffman R; Schaafsma TT; Krows ML; Thomas KK; Morrison S; Haugen HS; Kidoguchi L; Wener M; Greninger AL; Huang ML; Jerome KR; Wald A; Celum C; Chu HY; Baeten JM;
    Ann Intern Med; 2021 Mar; 174(3):344-352. PubMed ID: 33284679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir.
    Rahmani H; Davoudi-Monfared E; Nourian A; Nabiee M; Sadeghi S; Khalili H; Abbasian L; Ghiasvand F; Seifi A; Hasannezhad M; Ghaderkhani S; Mohammadi M; Yekaninejad MS
    Daru; 2020 Dec; 28(2):625-634. PubMed ID: 32857301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.